Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label venlafaxine extension in Japanese outpatients with generalized anxiety disorder
jRCT2031220234Completed
- Sponsor
- Mylan
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of venlafaxine in generalized anxiety disorder (GAD), sponsored by Mylan. Primary endpoint: Primary safety endpoints. Started Nov 2022; status: completed.
02
Drugs
venlafaxine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on jRCT2031220234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220234.